Cameron Daniel J, McWhinney Sean R
Northern Westchester Hospital, Mt. Kisco, New York, NY 10549, USA.
Department of Psychiatry, Dalhousie University, Halifax, NS B3H 2E2, Canada.
Antibiotics (Basel). 2023 Mar 1;12(3):493. doi: 10.3390/antibiotics12030493.
Individuals with Lyme disease can be very symptomatic. This survey compares the burden of illness for individuals with a history of Lyme disease (HLD) with individuals with a HLD who have either contracted COVID-19 or who have taken the COVID-19 vaccine. The findings describe the relative symptom burden among these three groups using a cross-sectional descriptive survey investigating the burden of Lyme disease in a pandemic. The survey includes the General Symptom Questionnaire-30 (GSQ-30), a brief self-report scale designed to assess the symptom burden in Lyme disease (LD). The results of this survey show that the overall burden of illness among individuals with HLD is not significantly different after contracting COVID-19 or after COVID-19 vaccination. A new survey will be needed to better understand why one in five individuals with a HLD reported long COVID after contracting COVID-19. These results should help clinicians and their patients to discuss the consequences of contracting a COVID-19 infection or being vaccinated against COVID-19.
莱姆病患者可能症状非常明显。本调查比较了有莱姆病病史（HLD）的个体与感染过新冠病毒或接种过新冠疫苗的有莱姆病病史个体的疾病负担。研究结果通过一项横断面描述性调查描述了这三组人群的相对症状负担，该调查旨在研究大流行期间莱姆病的负担。该调查包括一般症状问卷-30（GSQ-30），这是一个简短的自我报告量表，旨在评估莱姆病（LD）的症状负担。本次调查结果表明，感染新冠病毒后或接种新冠疫苗后，有莱姆病病史个体的总体疾病负担没有显著差异。需要进行一项新的调查，以更好地了解为什么五分之一有莱姆病病史的个体在感染新冠病毒后报告出现了长期新冠症状。这些结果应有助于临床医生及其患者讨论感染新冠病毒或接种新冠疫苗的后果。
